Pharma Pulse 6/6/24: OpenAI Insiders Warn of a ‘Reckless’ Race for Dominance, Three Ways to Close the Urgent Talent Gap & more


The latest news for pharma industry insiders.

Three Ways to Close the Urgent Talent Gap

The industry has struggled to recruit talent for years, and the challenge is only getting more difficult. Pharma companies need to recruit differently.

Poor Cardiovascular Health in Women Linked to Cognitive Decline in Midlife

Data show women with poor cardiovascular health may have an increased risk of early signs of cognitive decline in midlife.

Operational Oversight in Clinical Research: Integrations and Insights

Learn how IQVIA’s CDAS technology and services can provide an efficient path to consolidating and harmonizing data across any provider source, ensuring high quality oversight of outsourced clinical trial activities.

OpenAI Insiders Warn of a ‘Reckless’ Race for Dominance

A group of current and former employees is calling for sweeping changes to the artificial intelligence industry, including greater transparency and protections for whistle-blowers.

First FDA-Approved Phase II Stem Cell Treatment Study Shows Significant Improvements in Progressive MS Patients

The Tisch MS Research Center of New York, the world’s largest MS research center, has announced publication of the results of its FDA-approved Phase II stem cell treatment study in a leading stem cell journal, Stem Cell Research & Therapy. The study, which focused on Progressive MS patients, did not meet its primary endpoint but showed improvements in multiple areas – including walking speed, bladder function, and gray matter volume – for patients with significant disability.

Tower Cold Chain on LinkedIn:

In light of the UN's #WorldEnvironmentDay, today we reflect on the critical role of sustainability in every industry, including pharma. Tower's article in Pharmaceutical Commerce Magazine explores how realistic net-zero goals can be achieved through innovative temperature-controlled logistics.

Discover how the pharmaceutical sector is balancing operational efficiency with sustainability to meet carbon neutrality targets:

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs

© 2024 MJH Life Sciences

All rights reserved.